It was analyzed in a one‐arm study with insulin‐treated T1D and T2D patients and showed similar average reductions after 6 months of 0.5% ± 0.6 percentage points (p = 0.045, d = 0.81) [23]. This evidence concerns the gene INS and type 1 diabetes mellitus.